Prognostic Value Analysis of Mutational and Clinicopathological Factors in Non-Small Cell Lung Cancer

@inproceedings{Li2014PrognosticVA,
  title={Prognostic Value Analysis of Mutational and Clinicopathological Factors in Non-Small Cell Lung Cancer},
  author={Chenguang Li and Ligang Hao and Yue Li and Shengguang Wang and Hui Chen and Lianmin Zhang and Bin Ke and Yuesong Yin and Haijin Suo and Bingsheng Sun and Bin Zhang and Changli Wang},
  booktitle={PloS one},
  year={2014}
}
INTRODUCTION Targeting activating oncogenic driver mutations in lung adenocarcinoma has led to prolonged survival in patients harboring these specific genetic alterations. The prognostic value of these mutations has not yet been elucidated. The prevalence of recently uncovered non-coding somatic mutation in promoter region of TERT gene is also to be validated in lung cancer. The purpose of this study is to show the prevalence, association with clinicalpathological features and prognostic value… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Similar Papers

Loading similar papers…